Kang MS, Shin M, Ottoy J, Aliaga AA, et al. Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic. J Cereb Blood Flow Metab 2022;42:788-801.
PMID: 34378436